2. Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 2016;17:e383-9
3. Kim KH, Kang SJ, Choi J, Kong D, Seol HJ, Nam D, et al. Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. J Neurosurg 2019;130:1740-9
4. Kondziolka D, Patel AD, Kano H, Flickinger JC, Lunsford LD. Long-term outcomes after gamma knife radiosurgery for meningiomas. Am J Clin Oncol 2016;39:453-7
5. Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA. Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 2003;55:1000-5
8. Huttner HB, Bergmann O, Salehpour M, El Cheikh R, Nakamura M, Tortora A, et al. Meningioma growth dynamics assessed by radiocarbon retrospective birth dating. EBioMedicine 2018;27:176-81
10. Nakasu S, Fukami T, Nakajima M, Watanabe K, Ichikawa M, Matsuda M. Growth pattern changes of meningiomas: long-term analysis. Neurosurgery 2005;56:946-55. discussion 946-55
11. Soon WC, Fountain DM, Koczyk K, Abdulla M, Giri S, Allinson K, et al. Correlation of volumetric growth and histological grade in 50 meningiomas. Acta Neurochir (Wien) 2017;159:2169-77
12. Lee EJ, Kim JH, Park ES, Kim YH, Lee JK, Hong SH, et al. A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. J Neurosurg 2017;127:971-80
13. Lee EJ, Park JH, Park ES, Kim JH. “Wait-and-See” strategies for newly diagnosed intracranial meningiomas based on the risk of future observation failure. World Neurosurg 2017;107:604-11
14. Prabhu VC, Melian E, Germanwala AV, Solanki AA, Borys E, Barton K, et al. Cranial base meningiomas. World Neurosurg 2018;109:258-62
15. Morimoto M, Yoshioka Y, Shiomi H, Isohashi F, Konishi K, Kotsuma T, et al. Significance of tumor volume related to peritumoral edema in intracranial meningioma treated with extreme hypofractionated stereotactic radiation therapy in three to five fractions. Jpn J Clin Oncol 2011;41:609-16
16. Mahadevan A, Floyd S, Wong E, Chen C, Kasper E. Clinical outcome after hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors. Comput Aided Surg 2011;16:112-20
17. Bledsoe JM, Link MJ, Stafford SL, Park PJ, Pollock BE. Radiosurgery for large-volume (> 10 cm3) benign meningiomas. J Neurosurg 2010;112:951-6